RE:RE:chartPromotion and exposure. Insiders and funds are not loaded up like they are for nothing.Both Beacon Securities and Stone Castle Investments have large positions in this stock with price targets of .50. With continued improvement in EBITBA, natural organic growth and some more key aquisitions the PR machine should kick into high gear. Other analysts and fund managers will take notice. PHM is most definately on a few watch lists but they have to keep working on losing the stigma and stench of the Daislin and Greene days. Ryan Irvine of Keystocks has made Viamed (its spinoff sister company) their NUMBER ONE PICK. This can happen here as they are similar but differnt companies. PHM was one of their top picks 4 years ago so you know even they are watching as at these prices there looks to be a very nice upside if progress continues.